Cellectis (CLLS) Goodwill & Intangibles (2013 - 2026)
Cellectis' (CLLS) quarterly Goodwill & Intangibles came in at -$33.0 million in Q1 2026, up 10.95% year-on-year from -$29.7 million in Q1 2025, and down 0.59% quarter-over-quarter from -$32.8 million in Q4 2025.
Cellectis (CLLS) Goodwill & Intangibles (2013 - 2026) Analysis & Trends
Cellectis' Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at -$33.0 million for Q1 2026.
- On a quarterly basis, Goodwill & Intangibles rose 10.95% year-over-year to -$33.0 million in Q1 2026; TTM through Mar 2026 was -$33.0 million, a 10.95% increase from a year earlier, with the FY2025 full-year figure at -$32.8 million, up 14.68% from the prior year.
- Goodwill & Intangibles fell to -$33.0 million in Q1 2026 per CLLS's latest filing, from -$32.8 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at -$19.6 million in Q1 2022 and bottomed at -$38.4 million in Q4 2024.
- The 5-year median for Goodwill & Intangibles is -$33.9 million (2022), against an average of -$33.0 million.
- Across the five-year window, Goodwill & Intangibles tumbled 249.74% in 2022 and climbed 14.68% in 2025, its largest moves.
- Year by year, Goodwill & Intangibles stood at -$27.9 million in 2022, then retreated by 29.16% to -$36.0 million in 2023, then decreased by 6.67% to -$38.4 million in 2024, then gained by 14.68% to -$32.8 million in 2025, then slipped by 0.59% to -$33.0 million in 2026.
- Per Business Quant, the three latest CLLS Goodwill & Intangibles figures stand at -$33.0 million (Q1 2026), -$32.8 million (Q4 2025), and -$31.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.98 Mn |
| Dec 31, 2025 | -32.78 Mn |
| Sep 30, 2025 | -31.88 Mn |
| Jun 30, 2025 | -32.73 Mn |
| Mar 31, 2025 | -37.03 Mn |
| Dec 31, 2024 | -38.42 Mn |
| Sep 30, 2024 | -34.46 Mn |
| Jun 30, 2024 | -37.42 Mn |
| Mar 31, 2024 | -36.57 Mn |
| Dec 31, 2023 | -36.02 Mn |
| Sep 30, 2023 | -36.84 Mn |
| Jun 30, 2023 | -36.36 Mn |
| Mar 31, 2023 | -27.83 Mn |
| Dec 31, 2022 | -27.89 Mn |
| Sep 30, 2022 | -33.92 Mn |
| Jun 30, 2022 | -28.04 Mn |
| Mar 31, 2022 | -19.56 Mn |
| Dec 31, 2021 | -16.17 Mn |
| Sep 30, 2021 | -11.79 Mn |
| Jun 30, 2021 | -8.02 Mn |